This inventor holds 6 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: University of Michigan, Bayer Corporation, Other. Active years: 1999-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Harland, MI (US) (1999)
- Brighton, MI (US) (2004 - 2019)
Company Filing History:
5 out of 3,525 
1 out of 1,013 
1 out of 834,453 Years Active: 1999-2019
Title: **The Innovative Contributions of Nicholas W. Lukacs**
Introduction
Nicholas W. Lukacs is an accomplished inventor based in Brighton, Michigan, known for his significant contributions to the field of biomedical research and innovation. With a total of five patents to his name, Lukacs has focused primarily on developing methods and compositions that enhance healthcare treatments, particularly concerning fibrotic and tissue remodeling diseases.
Latest Patents
Lukacs's latest patents include innovative approaches such as the "Antibody Targeting Stem Cell Factor," which outlines methods and compositions related to inhibitors of stem cell factor. This invention details antibodies specifically targeting stem cell factor, providing potential therapeutic avenues for treating fibrotic and tissue remodeling diseases. Another notable patent is the "Stem Cell Factor Inhibitor," which similarly explores inhibitors of stem cell factor and their applicability in medical treatments. Both patents underscore his dedication to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Nicholas W. Lukacs has collaborated with prestigious institutions, including the University of Michigan. His work in these environments has cultivated an ecosystem of innovation that bridges academic research and practical application, enabling the development of breakthroughs in therapy and diagnostics.
Collaborations
In addition to his academic affiliations, Lukacs has worked alongside esteemed colleagues such as Cory Hogaboam and Steven L. Kunkel. These collaborations have enriched his research and contributed to the success of numerous projects, leveraging diverse expertise to enhance the impact of their work on health-related innovations.
Conclusion
Nicholas W. Lukacs exemplifies the spirit of innovation through his patents and collaborative efforts within the biomedical field. His focus on stem cell factors positions him as a key player in developing treatments that could potentially transform patient care. As he continues to innovate, the medical community looks forward to the implications of his work in addressing various health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile